ST
Star Therapeutics LLC
SEC filingOther · South San Francisco, CA
Amount raised$125Msold at filing
Total offering$125M
Investors in the raise21count reported to the SEC
FiledOct 6, 2025first sale Sep 22, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jason HaflerDirector
Nancy StaglianoDirector
Michelle CarpenterExecutive Officer
Carl GordonDirector
Matthew FustDirector
Amrit NagpalDirector
Beth SeidenbergDirector
Sandip PanickerExecutive Officer
Scott RobertsonExecutive Officer
Adam RosenthalExecutive Officer, Director
Maha KatabiDirector
Gary PatouExecutive Officer
Executive officers, directors and promoters as listed on the Form D.